237 related articles for article (PubMed ID: 30054763)
1. Association between IL-35 and coronary arterial lesions in children with Kawasaki disease.
Su Y; Feng S; Luo L; Liu R; Yi Q
Clin Exp Med; 2019 Feb; 19(1):87-92. PubMed ID: 30054763
[TBL] [Abstract][Full Text] [Related]
2. Relationship between IL-27 and coronary arterial lesions in children with Kawasaki disease.
Si F; Wu Y; Gao F; Feng S; Liu R; Yi Q
Clin Exp Med; 2017 Nov; 17(4):451-457. PubMed ID: 28108813
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels of interleukin-38 and interleukin-1β in the acute phase of Kawasaki disease in children].
Zhang XY; He T; Ling JY; Hu XF; Wen Y; Wei J; Lu HL
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Jul; 20(7):543-548. PubMed ID: 30022755
[TBL] [Abstract][Full Text] [Related]
4. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
5. Relationship between adipokines and coronary artery aneurysm in children with Kawasaki disease.
Liu R; He B; Gao F; Liu Q; Yi Q
Transl Res; 2012 Aug; 160(2):131-6. PubMed ID: 22683371
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Lai TJ; Tang CW; Lin CC; Ho TY; Liou HH; Ger LP
J Chin Med Assoc; 2013 Aug; 76(8):438-45. PubMed ID: 23769880
[TBL] [Abstract][Full Text] [Related]
7. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
Xie T; Wang Y; Fu S; Wang W; Xie C; Zhang Y; Gong F
Pediatr Rheumatol Online J; 2017 Mar; 15(1):17. PubMed ID: 28320400
[TBL] [Abstract][Full Text] [Related]
8. [Expression of interleukin-17A in serum of children with intravenous immunoglobulin-resistant Kawasaki disease and its clinical significance].
Li SY; Ding Y
Zhongguo Dang Dai Er Ke Za Zhi; 2023 Mar; 25(3):244-249. PubMed ID: 36946157
[TBL] [Abstract][Full Text] [Related]
9. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
[TBL] [Abstract][Full Text] [Related]
10. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
11. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
Chen J; Liu P; Hu W; Xu Y; Deng J
Clin Rheumatol; 2021 Oct; 40(10):4191-4197. PubMed ID: 34059986
[TBL] [Abstract][Full Text] [Related]
12. Clinical indicators combined with S100A12/TLR2 signaling molecules to establish a new scoring model for coronary artery lesions in Kawasaki disease.
Wu Y; Wang S; Zhou Y; Yang Y; Li S; Yin W; Ding Y
PLoS One; 2023; 18(10):e0292653. PubMed ID: 37824465
[TBL] [Abstract][Full Text] [Related]
13. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
14. Distribution of distinct subsets of circulating T follicular helper cells in Kawasaki disease.
Xu M; Jiang Y; Wang J; Liu D; Wang S; Yi H; Yang S
BMC Pediatr; 2019 Jan; 19(1):43. PubMed ID: 30704426
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
Wang Y; Wang W; Gong F; Fu S; Zhang Q; Hu J; Qi Y; Xie C; Zhang Y
Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of C1q/tumor necrosis factor-related protein-1 in children with Kawasaki disease.
Feng S; Su Y; Luo L; Jing F; Yi Q
Pediatr Res; 2018 May; 83(5):999-1003. PubMed ID: 29360808
[TBL] [Abstract][Full Text] [Related]
18. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
Hu P; Jiang GM; Wu Y; Huang BY; Liu SY; Zhang DD; Xu Y; Wu YF; Xia X; Wei W; Hu B
Clin Chim Acta; 2017 Aug; 471():76-80. PubMed ID: 28526535
[TBL] [Abstract][Full Text] [Related]
19. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
Liu R; Gao F; Huo J; Yi Q
Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
[TBL] [Abstract][Full Text] [Related]
20. Increased concentrations of growth differentiation factor-15 in children with Kawasaki disease.
Li G; Wang T; Li J; Chen P; Jia P; Zhao J; Duan Y; Liu D; Xu X; Liu B
Clin Chim Acta; 2020 Aug; 507():264-270. PubMed ID: 32387635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
